| | 24219-97-4 Basic information More.. |
| Product Name: | MIANSERIN | | Synonyms: | Dibenzoc,fpyrazino1,2-aazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-;MIANSERIN,1.0MG/MLINMETHANOL;Dibenzo[c,f]pyrazino[1,2-a]azepine, 1,2,3,4,10,14b-hexahydro-2-methyl- (8CI, 9CI);MIANSERIN (1.0MG/ML METHANOL);(14bS)-1,2,3,4,10,14b-Hexahydro-2-methyldibenzo[c,f]pyrazino[1,2-a]azepine;(14bS)-2-Methyl-1,2,3,4,10,14bα-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine;(S)-Mianserine;[14bS,(+)]-1,2,3,4,10,14bα-Hexahydro-2-methyldibenzo[c,f]pyrazino[1,2-a]azepine | | CAS: | 24219-97-4 | | MF: | C18H20N2 | | MW: | 264.36 | | EINECS: | 246-088-6 | | Mol File: | 24219-97-4.mol |  |
Use
Mianserin, a serotonin antagonist with antidepressant and
antihistaminic activity, was introduced in 1975 for the treatment of depressive
illness. Its use has since been associated with cases of severe blood dyscrasias,
particularly in elderly patients, including agranulocytosis, leucopenia and
granulocytopenia. Several drug regulatory authorities have reacted by stipulating
that blood counts should be monitored regularly during the first few months of
treatment and that administration should be discontinued immediately should any
signs possibly indicative of dyscrasia develop.
- Mianserin
-
- US $397.00-1290.00 / mg
- 2024-11-19
- CAS:24219-97-4
- Min. Order:
- Purity: 99.39%
- Supply Ability: 10g
- Mianserin USP/EP/BP
-
- US $1.10 / g
- 2021-07-27
- CAS:
- Min. Order: 1g
- Purity: 99.9%
- Supply Ability: 100 Tons min
- MIANSERIN
-
- US $1.00-2.00 / KG
- 2019-08-08
- CAS:24219-97-4
- Min. Order: 1KG
- Purity: 98%
- Supply Ability: 1kg,10kg,100kg
|
|
24219-97-4
Recommend Suppliers |
|